BridgeBio Pharma, Inc.
USD63.88
-1.48 (-2.26%)
CEO
Neil Kumar
IPO Date
2019-06-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$64.84
Prev. Close
$65.36
Day Low
$62.50
Day High
$65.08
52W Low
$37.57
52W High
$84.94
Market Cap
$12.51B
Volume
3.93M
| 6,725 |
| $68.30 |
| 26 May 2026 | Kumar Neil | director, officer: Chief Executive Officer | S-Sale | Disposed | 5,072 | $69.22 |
| 26 May 2026 | Kumar Neil | director, officer: Chief Executive Officer | S-Sale | Disposed | 11,250 | $70.48 |
| 26 May 2026 | Kumar Neil | director, officer: Chief Executive Officer | S-Sale | Disposed | 800 | $70.92 |
| 19 May 2026 | Trimarchi Thomas | President and CFO | F-InKind | Disposed | 22,781 | $66.13 |
| 19 May 2026 | Trimarchi Thomas | President and CFO | S-Sale | Disposed | 10,456 | $64.82 |
| 19 May 2026 | Trimarchi Thomas | President and CFO | S-Sale | Disposed | 3,195 | $65.95 |
| 19 May 2026 | Kumar Neil | director, officer: Chief Executive Officer | M-Exempt | Acquired | 33,544 | $0.00 |
| 19 May 2026 | Kumar Neil | director, officer: Chief Executive Officer | M-Exempt | Acquired | 19,599 | $0.00 |
| $1,001 - $15,000 |
| 8 Apr 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 8 Apr 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 8 Apr 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 8 Apr 2026 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 13 Oct 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |
| 12 Sept 2025 | Gilbert Cisneros | Gilbert Cisneros | Purchase | $1,001 - $15,000 |